Boston Scientific Corporation vs JetBlue Airways Corporation — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while JetBlue Airways Corporation trades at $5.81 (market cap $2.19B). The key difference: Boston Scientific Corporation is far larger — about 33.9× JetBlue Airways Corporation's market cap, and JetBlue Airways Corporation is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | JBLU | |
|---|---|---|
Market Cap | $74.19B | $2.19B |
Sector | Health | Industrials |
52-Week High | $108.14 | $6.46 |
52-Week Low | $42.63 | $4.03 |
Enterprise Value | $86.27B | $9.56B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →